Your browser doesn't support javascript.
loading
Structure-activity relationship and pharmacokinetic studies of sotrastaurin (AEB071), a promising novel medicine for prevention of graft rejection and treatment of psoriasis.
Wagner, Jürgen; von Matt, Peter; Faller, Bernard; Cooke, Nigel G; Albert, Rainer; Sedrani, Richard; Wiegand, Hansjörg; Jean, Christian; Beerli, Christian; Weckbecker, Gisbert; Evenou, Jean-Pierre; Zenke, Gerhard; Cottens, Sylvain.
Affiliation
  • Wagner J; Novartis Institutes for BioMedical Research, Basel CH-4002, Switzerland. juergen.wagner@novartis.com
J Med Chem ; 54(17): 6028-39, 2011 Sep 08.
Article in En | MEDLINE | ID: mdl-21797275

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Pyrroles / Quinazolines / Lymphocyte Activation / Protein Kinase Inhibitors / Graft Rejection Limits: Animals / Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2011 Type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Pyrroles / Quinazolines / Lymphocyte Activation / Protein Kinase Inhibitors / Graft Rejection Limits: Animals / Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2011 Type: Article Affiliation country: Switzerland